all report title image
  • Published In : May 2023
  • Code : CMI5691
  • Pages : 168
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic
Ingographics Image

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of β-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

  • This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

  • Global Rapid Diagnostics Market, By Product:
    • Consumables
    • Instruments/Analysers
  • Global Rapid Diagnostics Market, By Prescription:
    • Professional Diagnostics
    • At-Home/OTC-Based Testing
  • Global Rapid Diagnostics Market, By Application:
    • Blood Glucose Testing
    • Cardiometabolic Testing
    • Infectious Disease Testing
    • Blood Coagulation Testing
    • Hematology Testing
    • Cancer Testing
    • Drug of Abuse Testing
    • Pregnancy and Fertility/Ovulation Testing
  • Global Rapid Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Laboratories
    • Individuals/Home Healthcare Settings
    • Others
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Abbott
    • Danaher
    • Quidel
    • BD
    • LifeScan
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Ascensia Diabetes Care Holdings

Table of Contents:

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product
      • Market Snapshot, By Prescription
      • Market Snapshot By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Rise in prevalence of chronic/infectious disease
      • Stringent regulations and rapid diagnostics challenges
      • The outbreak of COVID-19 (global pandemic)
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product launch/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Rapid Diagnostics Market – Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact
  5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 - 2030
      • Segment Trends
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Instruments/Analysers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 - 2030
      • Segment Trends
    • Professional Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • At-Home/OTC-Based Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 - 2030
      • Segment Trends
    • Blood Glucose Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Cardiometabolic Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Infectious Disease Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Blood Coagulation Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Hematology Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Cancer Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Drug of Abuse Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Pregnancy and Fertility/Ovulation Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 - 2030
      • Segment Trends
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Individuals/Home Healthcare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 - 2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  10. Competitive Landscape
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Danaher
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Quidel
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • BD
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LifeScan
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siemens Healthineers
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • F. Hoffmann-La Roche
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ascensia Diabetes Care Holdings
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Analyst Views
  11. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "Global Global Rapid Diagnostics Market” - forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo